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        Introduction 
  Stimulation of the T cell receptor (TCR) by peptide  –  major 
histocompatibility complex on an antigen-presenting cell (APC) 
triggers the activation of biochemical signaling pathways that 
not only lead to changes in gene transcription but also cytoskel-
etal reorganization resulting in the formation of the immuno-
logical synapse (IS) (  Billadeau et al., 2007  ). Through a process 
known as   “  inside-out  ”   signaling, the activation of intracellu-
lar signaling proteins in response to TCR ligation ultimately 
results in the regulation of cell surface integrins (clustering 
and affinity maturation) required for the stable interaction 
between the T cell and APC (  Kinashi, 2005  ). The resulting 
characteristic structure of the IS contains signaling proteins in 
the center of the supramolecular activation complex (SMAC), 
whereas integrins and integrin scaffolding proteins such as ta-
lin are found in the peripheral SMAC (  Anton van der Merwe 
et al., 2000  ). 
  Integrins are heterodimeric cell surface receptors that are 
responsible for cell adhesion during several biological processes 
or, in the case of T cells, conjugation to an APC or target cell. 
Among the different integrins expressed by T cells, LFA-1 (   L    2 ) 
has been shown to be critical for conjugate formation and binds 
to its ligand ICAM-1 found on APCs (  Dustin and Springer, 
1989  ). In addition, VLA-4 (    4    1  ) also functions in T cell activa-
tion by binding to VCAM-1 and the extracellular matrix protein 
fi  bronectin (  Mobley et al., 1994  ), functioning as a costimulatory 
molecule (  Shimizu et al., 1990  ), and also localizes to the periph-
eral SMAC of the IS (  Mittelbrunn et al., 2004  ) where it might 
interact with CD14 on the APC ( Humphries and Humphries, 2007 ). 
The regulation of integrins can occur as a result of clustering of 
individual subunits on the cell surface, thereby increasing avidity, 
or by changes in the conformation of the integrin itself, thereby 
increasing affi  nity. Although TCR engagement leads to changes 
in both integrin affi  nity and avidity, the molecular mechanisms 
that control these individual processes remain largely unknown. 
W
AVE2 regulates T cell receptor (TCR)  –  stimulated 
actin cytoskeletal dynamics leading to both 
integrin clustering and afﬁ  nity maturation. 
Although WAVE2 mediates integrin afﬁ  nity maturation by 
recruiting vinculin and talin to the immunological synapse 
in an Arp2/3-dependent manner, the mechanism by 
which it regulates integrin clustering is unclear. We show 
that the Abl tyrosine kinase associates with the WAVE2 
complex and TCR ligation induces WAVE2-dependent 
membrane recruitment of Abl. Furthermore, we show that 
WAVE2 regulates TCR-mediated activation of the integrin 
regulatory guanosine triphosphatase Rap1 via the recruit-
ment and activation of the CrkL  –  C3G exchange complex. 
Moreover, we demonstrate that although Abl does not 
regulate the recruitment of CrkL  –  C3G into the membrane, 
it does affect the tyrosine phosphorylation of C3G, which 
is required for its guanine nucleotide exchange factor 
  activity toward Rap1. This signaling node regulates not 
only TCR-stimulated integrin clustering but also afﬁ  nity 
maturation. These ﬁ  ndings identify a previously unknown 
mechanism by which the WAVE2 complex regulates TCR 
signaling to Rap1 and integrin activation.
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to the activation of Rap1. Overall, these data demonstrate that 
the WAVE2 complex participates in the localization of key reg-
ulators of Rap1, leading to integrin clustering and affi  nity matu-
ration during T cell activation. 
  Results 
  WAVE2 is involved in TCR- and PMA-
mediated adhesion to ﬁ  bronectin and 
ICAM-1 in normal human T cells 
  We have previously shown that WAVE2 is involved in TCR-
stimulated changes in both integrin affi  nity and avidity in Jurkat 
T cells (  Nolz et al., 2007  ). To determine if WAVE2 participated 
in adhesion in nontransformed primary human T cells, siRNA 
duplexes against WAVE2 were transfected into purifi  ed human 
CD4 
+   T cells, and the amount of suppression was determined by 
immunoblot. In agreement with previously published data, sup-
pression of WAVE2 results in decreased protein levels of other 
WAVE complex members, including Abi-1 and 2, HEM-1, and 
PIR121 (  Fig. 1 A  ). 
[ID]FIG1[/ID]  Because protein levels of the WAVE2 com-
plex could be adequately decreased using this method, we next 
analyzed these cells for VLA-4  –  mediated adhesion to fi  bronectin 
in response to TCR stimulation. Stimulated T cells transfected 
with control siRNA showed limited basal binding to fi  bronectin 
but adhered readily to fi  bronectin in response to TCR stimula-
tion, although not to wells containing only BSA (  Fig. 1, B and C  ). 
However, cells in which WAVE2 had been suppressed were 
much less effi  cient at adhering to fi  bronectin at all concentrations 
tested (  Fig. 1, B and C  , left). 
  Fibronectin is an extracellular matrix protein and adhe-
sion to this molecule is mediated primarily through     1   integrins. 
In contrast, T cell  –  APC conjugation is primarily LFA-1 (    L    2 ) 
mediated through the association with its ligand ICAM-1 found 
on the surface of the APC. Therefore, we next tested whether 
normal human T cells required WAVE2 for adhesion to ICAM-1 
in response to TCR ligation. Similar to the results obtained with 
adhesion to fi  bronectin, WAVE2-suppressed T cells also demon-
strated an overall reduction in adhesion to ICAM-1 in response 
to TCR stimulation (  Fig. 1, B and C  , right). Collectively, these 
data confi  rm the results obtained in Jurkat T cells, where WAVE2 
is involved in TCR-mediated integrin activation leading to adhe-
sion through both     1   and     2   integrins. 
  WAVE2 regulates TCR-mediated activation 
of Rap1 
  Rap1 is a small GTPase of the Ras family, and numerous studies 
have demonstrated the importance of this protein in regulating 
TCR-mediated integrin clustering and affi  nity maturation (  Bos, 
2005  ). We have previously shown that WAVE2 regulates the 
clustering of integrins and the recruitment of talin and vinculin 
to the IS leading to high-affi  nity integrin binding (  Nolz et al., 
2007  ). Thus, the WAVE2 complex may be involved in Rap1 ac-
tivation leading to integrin clustering at the IS. We used shRNA 
against WAVE2 in the Jurkat T cell line and assessed Rap1 acti-
vation using a GST-tagged RalGDS GTPase binding domain 
(GBD). TCR-stimulated Jurkat T cells activated Rap1 rapidly, 
peaked at     1 min after stimulation, and returned to background 
  Recent studies have suggested that Rap1, a member of the 
Ras family of small GTPases, is a critical regulator of integrin 
activation in response to stimulation of both the TCR and chemo-
kine receptors. In fact, both expression of a constitutively active 
form of Rap1 using a transgenic mouse model (  Sebzda et al., 
2002  ) and the creation of a Rap1A knockout mouse (  Duchniewicz 
et al., 2006  ) have demonstrated the importance of this protein 
in regulating immune cell adhesion. Several effectors of Rap1 
(RAPL, PKD, and RIAM) have been described and each appears 
to be required for appropriate integrin clustering to occur in re-
sponse to receptor stimulation, whereas integrin affi  nity, when 
examined, was largely unaffected (  Katagiri et al., 2003  ;   Medeiros 
et al., 2005  ;   Menasche et al., 2007  ). Despite the fact that Rap1 
is a key regulator of integrin activation, neither the signaling path-
ways used by the TCR to activate Rap1 nor the specifi  c guanine 
nucleotide exchange factors (GEFs) that activate Rap1 have been 
completely elucidated. 
  The Abl family of tyrosine kinases has been implicated 
in regulating cell shape and motility through the regulation of 
F-actin dynamics in several cell types (  Hernandez et al., 2004  ). 
In fact, PDGF stimulation of fi  broblasts results in increased 
Abl kinase activity, as well as Abl-dependent F-actin  –  mediated 
membrane ruffl  ing (  Plattner et al., 1999  ). Abl kinases can poten-
tially regulate F-actin cytoskeletal changes through an association 
with the Abi (Abl-interactor) proteins, which interact directly 
with Arp2/3 (actin-related protein 2/3) regulatory WAVE pro-
teins (  Innocenti et al., 2004  ). More recently, it has been shown 
that T cells defi  cient for both Abl kinases (Abl and Arg) show 
profound defects in development, proliferation, and cytokine 
production (  Gu et al., 2007  ). Although this study and others 
have demonstrated the importance of these proteins in regu-
lating cellular function, the mechanisms by which Abl controls 
actin-dependent processes in both immune and nonimmune cells 
remain obscure. 
  It has been previously shown that TCR-stimulated changes 
in integrin avidity and affi  nity are dependent on the cytoskeletal 
regulatory protein WAVE2 and the Arp2/3 complex (  Nolz et al., 
2006  ;   Gomez et al., 2007  ). It was subsequently found that the 
integrin scaffolding protein vinculin is also involved in TCR-
mediated integrin activation and regulates integrin affi  nity mat-
uration through an association with WAVE2  –  Arp2/3 complex 
and recruitment of talin to the     -chain of the integrin (  Nolz 
et al., 2007  ). In contrast to WAVE2-depleted T cells, which fail 
to accumulate F-actin or integrins at the IS, vinculin-depleted 
T cells accumulate F-actin and integrins, thus suggesting that 
WAVE2 regulates both aspects of integrin regulation, whereas 
other proteins, such as Rap1 effectors and vinculin, are respon-
sible for regulating either affi  nity or avidity in response to 
TCR engagement. 
  Because of the involvement of WAVE2 and Rap1 in regu-
lating integrin avidity, we sought to determine whether WAVE2 
contributed to TCR-mediated activation of Rap1. Our data dem-
onstrate that the WAVE2 complex is required for TCR-mediated 
Rap1 activation. We show that the tyrosine kinase Abl is asso-
ciated with the WAVE2 complex in T cells and that WAVE2 is 
involved in the TCR-stimulated plasma membrane recruitment 
of the tyrosine kinase Abl and the CrkL  –  C3G complex, leading 1233 WAVE2 REGULATES TCR-MEDIATED RAP1 ACTIVATION   • Nolz et al. 
to the cell membrane after receptor stimulation (  Fig. 2, D and E  ). 
The interaction between PKD and activated Rap1 is also re-
quired for integrin clustering to occur in response to both TCR 
and PMA stimulation (  Medeiros et al., 2005  ). We therefore de-
termined whether WAVE2 suppression affected the recruitment 
of Rap1 or PKD to the cell membrane after cellular activation. 
Indeed, localization of Rap1 and PKD into the cell membrane 
is diminished after stimulation with either anti-CD3 or PMA 
in WAVE2-suppressed T cells (  Fig. 2, D and E  ). In addition to 
PKD, GTP-Rap1 also associates with RapL, which will, in turn, 
form a complex with the kinase Mst1 (  Katagiri et al., 2006  ), 
leading to its phosphorylation and activation, an event which 
is required for integrin clustering. Using an antibody that de-
tects phosphorylation of Mst1 on threonine 183 (  Katagiri et al., 
2006  ), phosphorylated Mst1 could be detected in purifi  ed 
human CD4 
+   T cells after CD3 stimulation. However, WAVE2-
suppressed CD4 
+   T cells fail to effi  ciently activate Mst1 in 
response to TCR stimulation (  Fig. 2 F  ). Collectively, these data 
demonstrate that the WAVE2 complex is an essential compo-
nent of signaling pathways initiated by the TCR, resulting in 
the plasma membrane localization and activation of Rap1 and 
its downstream effectors. 
  TCR-mediated activation of Rap1 
is dependent on the adaptor CrkL 
and the GEF C3G 
  The GEF C3G can associate with the adaptor protein CrkL, 
and this CrkL  –  C3G complex has been implicated in regulating 
Rap1 activation in both BCR-ABL  –  transformed chronic myelog-
enous leukemia cells and other cell types (  Sattler and Salgia, 
1998  ;   Arai et al., 1999  ;   Ichiba et al., 1999  ;   Sakakibara et al., 
2002  ). Additionally, it has been proposed that this complex of 
levels by 5 min (  Fig. 2 A  ). 
[ID]FIG2[/ID]  In contrast, WAVE2-suppressed cells 
were less effective at activating Rap1 in response to TCR stimu-
lation when compared with the control cells (  Fig. 2 A  ). Simi-
larly, suppression of WAVE2 using siRNA in both human CD4 
+  
and CD8 
+   T cells resulted in attenuated Rap1 activation down-
stream of the TCR (  Fig. 2, B and C  ). The residual TCR-stimulated 
Rap1 activation seen in WAVE2-depleted cells may be caused by 
other TCR-regulated signaling pathways coupling to Rap1 acti-
vation or to incomplete suppression of WAVE2. 
  Because WAVE2 regulates actin cytoskeletal remodeling, it 
is possible that actin reorganization may impact activation of Rap1. 
Cytochalasin D and latrunculin B are two actin-destabilizing 
toxins that prevent actin polymerization through different mech-
anisms. Treatment of purifi  ed human CD4 
+   T cells with either 
of these actin-destabilizing drugs resulted in impaired Rap1 
activation in response to TCR stimulation (Fig. S1 A, available 
at http://www.jcb.org/cgi/content/full/jcb.200801121/DC1). 
We had previously shown that WAVE2-dependent actin dynamics 
were required to recruit vinculin to the IS. We therefore exam-
ined whether vinculin suppression would affect TCR-stimulated 
Rap1 activation. In contrast to suppression of WAVE2 or pharma-
cological inhibition of actin dynamics, suppression of vinculin 
did not affect Rap1 activation after TCR ligation (Fig. S1 B). 
Thus, although actin dynamics (either WAVE2-dependent or 
-independent) are required for TCR-mediated Rap1 activation 
to occur, it is not mediated through vinculin. 
  Several downstream effectors of GTP-Rap1 have been iden-
tifi  ed that are required for the activation of inside-out signaling 
pathways leading to integrin activation. The nonconventional 
PKC isoform PKD (aka, PKC  ) binds to activated Rap1 through 
a noncanonical interaction within the pleckstrin homology do-
main of the protein, and both activated Rap1 and PKD localize 
  Figure 1.       WAVE2 is required for TCR-medi-
ated adhesion to both ﬁ  bronectin and ICAM-1 
in primary human CD4 
+   T cells.   (A) Puriﬁ  ed hu-
man CD4 
+   T cells were transfected with either 
control siRNA (siControl) or siRNA against 
WAVE2 (siWAVE2). Whole cell extracts were 
then analyzed by immunoblot for expression of 
WAVE2, Abi-1/2, HEM-1, PIR121, and ZAP-70. 
(B and C) Cells were transfected as in A, 
stained with calcein AM, and added to a 96-
well plate coated with increasing concentra-
tions of ﬁ  bronectin or ICAM-1-Fc (B) or 0.3   μ  g 
of each (C). Cells were then left unstimulated 
(C) or stimulated with anti-CD3 (B and C), and 
adhesion was determined as described in 
Materials and methods. Error bars represent SD.     JCB • VOLUME 182 • NUMBER 6 • 2008  1234
ing integrin clustering, CrkL and C3G are also required to gen-
erate the high-affi  nity state of     1   integrins, as demonstrated by 
an impaired ability to bind soluble VCAM-1-Fc in response to 
either TCR stimulation or treatment with PMA ( Fig. 4 B ). These 
data demonstrate that the CrkL  –  C3G complex regulates inside-
out signaling pathways, leading to changes in both integrin af-
fi  nity and avidity. 
  WAVE2 regulates the activation of 
the CrkL  –  C3G Rap1 exchange complex 
downstream of the TCR 
  Because CrkL and C3G are both required for TCR-mediated 
Rap1 activation and WAVE2-suppressed T cells are impaired in 
Rap1 activation, we next determined whether CrkL is recruited to 
the IS. For this experiment, we used latex beads coated with con-
trol mouse IgG or anti-CD3 because the high level of expression 
of CrkL in the Nalm 6 B cell line impaired visualization of CrkL 
recruitment to the IS. We did not observe any colocalization of 
F-actin with either WAVE2 or CrkL when Jurkat T cells were 
stimulated with mouse IgG-coated beads (unpublished data). 
However, we observed recruitment of F-actin and WAVE2, as 
well as F-actin and CrkL to the cell –  bead contact site when stim-
ulating with anti-CD3  –  coated beads (  Fig. 5 A  ). 
[ID]FIG5[/ID]  
  Because WAVE2-suppressed T cells were found to be defi  -
cient in TCR-mediated Rap1 activation, we next wanted to de-
termine whether the activation of CrkL and C3G was linked to 
proteins is involved in T cell adhesion because T cells lacking 
either c-Cbl or Cbl-b, two negative regulators of CrkL  –  C3G 
signaling, have increased adhesion (  Shao et al., 2003  ;   Zhang 
et al., 2003  ). However, it is unclear whether this complex regu-
lates TCR-stimulated Rap1 activation. To determine whether 
C3G was required for Rap1 activation to occur in response to 
TCR stimulation, two different shRNAs against C3G were used 
in Jurkat T cells. Suppression of C3G dramatically impaired 
Rap1 activation (  Fig. 3 A  ) and adhesion to fi  bronectin (  Fig. 3 B  ) 
in response to TCR stimulation. 
[ID]FIG3[/ID]  Furthermore, suppression of 
CrkL using siRNA in human CD4 
+   T cells led to a defect in 
Rap1 activation (  Fig. 3 C  ). Finally, suppression of CrkL in puri-
fi  ed human CD4 
+   T cells impairs TCR-dependent adhesion to 
both fi  bronectin (  Fig. 3 D  ) and ICAM-1 (  Fig. 3 E  ). These data 
reveal that the CrkL  –  C3G complex is required for TCR-stimulated 
activation of Rap1 leading to integrin adhesion. 
  Effectors of Rap1 have been implicated in the regulation 
of integrin clustering and affi  nity maturation in response to both 
TCR and chemokine receptor stimulation in T cells (  Katagiri 
et al., 2003  ;   Medeiros et al., 2005  ). In agreement with this, 
 localization  of     1   integrins to the IS is impaired in both CrkL- 
and C3G-suppressed Jurkat T cells interacting with superantigen-
pulsed Raji B cells (  Fig. 4 A  ). 
[ID]FIG4[/ID]  Signifi  cantly, accumulation of 
F-actin at the IS was not affected in Jurkat T cells suppressed 
for either CrkL or C3G (Fig. S2 A, available at http://www.jcb
.org/cgi/content/full/jcb.200801121/DC1). In addition to affect-
  Figure 2.       WAVE2 is required for TCR-mediated Rap1 activation.   (A) Jurkat T cells were transfected with either control vector or WAVE2 suppression vector 
and allowed to recover for 72 h. Cells were then stimulated with anti-CD3 for the indicated time, lysed, and GTP-bound Rap1 was detected using GST-
RalGDS GBD and immunoblot. (B and C) Same as A except puriﬁ  ed human CD4 
+   or CD8 
+   T cells were transfected with either siControl or siWAVE2 and 
stimulated with anti-CD3 for the indicated times. Black lines indicate that intervening lanes have been spliced out. (D and E) Jurkat T cells were transfected 
with the indicated vectors and stimulated with either anti-CD3 or 50 ng/ml PMA for 2 min. Subsequently, cytosolic and membrane fractions were prepared 
and probed as indicated. (F) Puriﬁ  ed human CD4 
+   T cells were transfected as in B, stimulated with anti-CD3 over the indicated timecourse, and cell lysates 
were immunoblotted with a phospho-speciﬁ  c antibody against PAK (which cross-reacts with Mst1), total Mst1, and WAVE2. Numbers below top blots are 
arbitrary units based on densitometric analysis of the immunoblots.     1235 WAVE2 REGULATES TCR-MEDIATED RAP1 ACTIVATION   • Nolz et al. 
for CrkL phosphorylation in response to TCR engagement, it does 
so in an F-actin  –  independent manner. 
  It has been proposed that phosphorylation of CrkL on 
Y207 inhibits its localization through an autoinhibitory mecha-
nism, where the SH2 domain of the protein binds with high 
 affi  nity to a phosphorylated tyrosine between the amino- and 
carboxy-terminal SH3 domains (  Feller et al., 1994  ;   Rosen et al., 
1995  ), thereby preventing the association with other binding 
partners and decreasing CrkL-mediated signaling. In fact, ex-
pression of an Y207F CrkL point mutant resulted in enhanced 
basal adhesion to fibronectin as compared with control and 
wild-type CrkL-expressing Jurkat T cells (Fig. S2, B and C). 
We therefore next determined which domains of CrkL were re-
quired for its phosphorylation and regulation of Rap1 after TCR 
ligation. Although wild-type CrkL underwent tyrosine phos-
phorylation, mutation of the critical residue within the SH2 
domain (R39A) prevented TCR-stimulated phosphorylation of 
CrkL, whereas mutation of either SH3 domain had no effect 
(  Fig. 5 D  ). In addition, we found that the CrkL SH2 domain and 
N-terminal SH3 domain (which binds to C3G) are involved in 
the WAVE2 complex. CrkL is phosphorylated on Y207 by the 
Abl tyrosine kinase (  de Jong et al., 1997  ;   Zipfel et al., 2004  ). 
We therefore assessed whether WAVE2 suppression affected the 
phosphorylation of CrkL on Y207. Indeed, in response to TCR 
stimulation, CrkL is phosphorylated on Y207, and this phosphory-
lation was diminished in WAVE2-suppressed T cells (  Fig. 5 B  ), 
suggesting the possibility that CrkL was not getting effectively 
recruited in WAVE2-suppressed cells. Interestingly, the effect 
of WAVE2 on CrkL phosphorylation appears to be independent 
of its ability to bind the Arp2/3 complex because reexpression of 
a     VCA version of WAVE2, as well as the wild-type version, 
are both suffi  cient to restore CrkL phosphorylation in WAVE2-
suppressed T cells (  Fig. 5 C  ). Moreover, suppression of Arp2/3 
in Jurkat T cells does not affect Y207 phosphorylation of CrkL 
in response to TCR stimulation (JCN and DDB; unpublished 
data). In agreement with this fi  nding, treatment of T cells with 
the actin depolymerizing agents cytochalasin D or latrunculin B, 
which abrogates Rap1 activation after TCR ligation, has no 
  affect on TCR-stimulated tyrosine phosphorylation of CrkL 
(Fig. S1 C). These data suggest that although WAVE2 is required 
  Figure 3.       C3G and CrkL are required for 
TCR-mediated activation of Rap1 and adhe-
sion.   (A) Jurkat T cells were transfected with 
the indicated suppression vectors, stimulated 
with anti-CD3, and Rap1 activation was de-
termined. (B) Cells were transfected as in A, 
stained with calcein AM, and adhesion to 
0.3   μ  g/well ﬁ   bronectin was determined. 
(C) Puriﬁ   ed human CD4 
+   T cells were trans-
fected with the indicated siRNAs and Rap1 
activation after anti-CD3 cross-linking was de-
termined as described in Materials and meth-
ods. Numbers below top blots are arbitrary 
units based on densitometric analysis of the 
immunoblots. (D and E) Puriﬁ  ed human CD4 
+   
T cells were transfected with the indicated 
siRNAs and analyzed for the ability to adhere 
to 0.1   μ  g/well fibronectin or 0.3   μ  g/ml 
ICAM-1-Fc in response to either anti-CD3 or 
50 ng/ml PMA. Error bars represent SD.     JCB • VOLUME 182 • NUMBER 6 • 2008  1236
tion, C3G, although required for Rap1 activation, is not required 
for phosphorylation of CrkL on Y207 (  Fig. 5 G  ). These data are 
consistent with the observation that although the N-terminal SH3 
domain of CrkL is not required for TCR-stimulated phosphory-
lation of CrkL, it is required for Rap1 activation. 
  The WAVE2 complex regulates Abl tyrosine 
kinase membrane recruitment 
  Abl tyrosine kinases have been implicated in regulating both 
cytoskeletal dynamics and cellular adhesion (  Woodring et al., 
2003  ). In addition, WAVE2 is constitutively linked to the adap-
tor protein Abi-1 or Abi-2, which were identifi  ed as Abl kinase-
interacting proteins ( Dai and Pendergast, 1995 ;   Shi et al., 1995 ). 
regulating Rap1 activation downstream of the TCR (  Fig. 5 E  ). 
Collectively, these results suggest that the WAVE2 complex is 
involved in the recruitment of CrkL (via its SH2 domain) for 
optimal TCR-stimulated Rap1 activation (  Fig. 6 C  ). 
[ID]FIG6[/ID]  
  The Rap1 GEF C3G can associate with the N-terminal SH3 
domain of CrkL (  Feller et al., 1995  ), and phosphorylation of 
Y504 within C3G regulates its GEF activity (  Ichiba et al., 1999  ). 
To determine if C3G phosphorylation was affected by WAVE2 
suppression, C3G protein was purifi  ed from cellular lysate using 
a GST N-terminal SH3 domain of CrkL (CrkL SH3-N; Fig. S2 D). 
Using this method, tyrosine phosphorylated C3G could be de-
tected in TCR-stimulated cells, but this phosphorylation was 
diminished in WAVE2-suppressed Jurkat T cells (  Fig. 5 F  ). In addi-
  Figure 4.       CrkL and C3G regulate both in-
tegrin afﬁ   nity and avidity.   (A) Jurkat T cells 
were transfected with GFP-expressing control 
or suppression vectors targeting either CrkL 
or C3G. T cells (green) were allowed to form 
conjugates with superantigen (SEE)-pulsed Raji 
B cells (blue) and stained for       1   integrin (red) 
to determine localization of integrins to the IS. 
Data shown is the mean of three independent 
experiments. Bar, 5   μ  m. (B) Cells were trans-
fected as in A and analyzed for their ability to 
bind soluble VCAM-1  –  Fc in response to either 
anti-CD3 or PMA stimulation. Stimulation with 
Mn 
2+   serves as a positive control for VCAM-1  –
  Fc binding. Histograms represent VCAM-1  –  Fc 
binding in cell populations gated on differ-
ent levels of GFP expression (negative, low, 
and high).     1237 WAVE2 REGULATES TCR-MEDIATED RAP1 ACTIVATION   • Nolz et al. 
fraction of TCR-stimulated cells (Fig. S4, C and D). Collec-
tively, these data suggest that Abl is associated with the WAVE2 
complex and that TCR stimulation results in Abl membrane re-
cruitment where it can then phosphorylate its target substrates. 
  The defect of CrkL phosphorylation on Y207 in WAVE2-
suppressed T cells suggested to us that Abl might not be prop-
erly recruited to its substrates without the WAVE2 complex. 
To test this, we first examined Abl cellular localization in 
T cell  –  Nalm 6 B cell conjugates formed with control and WAVE2-
suppressed cells. Although Abl is effi  ciently recruited to the IS 
in control transfected T cells stimulated with SEE, Abl recruit-
ment is diminished in T cells suppressed for WAVE2 (  Fig. 6 B  ). 
To validate these results biochemically, membrane and cytosolic 
fractions from both control and WAVE2-suppressed Jurkat T 
cells were analyzed after TCR stimulation. Indeed, stimulation 
We therefore asked whether Abl is associated with the WAVE2 
complex in T cells. Indeed, using two different antibodies against 
WAVE2, we found that Abl can be coimmunoprecipitated with 
the WAVE2 complex from human CD4 
+  T cells (Fig. S3 A, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200801121/DC1). 
In addition, the SH3 domains of both Abi-1 and Abi-2 inter-
act with Abl independently of the rest of the WAVE2 complex, 
whereas the SH3 domain of IRSp53, which binds the proline-
rich region of WAVE2 directly, precipitates the entire WAVE2 
complex, including Abl (Fig. S3 A). Additionally, Abl co-
immunoprecipitates with WAVE2 from stimulated human CD4 
+  
T cells throughout TCR stimulation (  Fig. 6 A  ). Using an in vitro 
kinase assay, cytoplasmic Abl kinase activity does not appear to 
change in response to TCR stimulation (Fig. S4, A and B), but 
there is an increase in Abl kinase activity from the membrane 
  Figure 5.       WAVE2 is required for phosphory-
lation of CrkL and C3G.   (A) Jurkat T cells were 
stimulated with OKT3-bound beads, and the 
localization of WAVE2 (green) or CrkL (green) 
and F-actin (red) was analyzed by confocal 
microscopy. Representative images are shown. 
Bar, 5   μ  m. (B) Jurkat T cells were transfected 
with the indicated vectors and stimulated with 
anti-CD3. Whole cell extracts were prepared 
and immunoblotted for pCrkL (Y207), total 
CrkL, and WAVE2. (C) Jurkat T cells were 
transfected with the indicated suppression/re-
expression vectors, stimulated with anti-CD3, 
and whole cell extracts were immunoblotted 
as in B. (D) Jurkat T cells were transfected with 
the indicated expression vectors, stimulated 
with anti-CD3, and lysates immunoblotted with 
the indicated antibodies. (E) Jurkat T cells were 
transfected with control vector, CrkL-suppres-
sion vector, or suppression/reexpression vec-
tors, which reexpressed either wild-type CrkL 
or point mutants disrupting the function of the 
SH2, SH3-N, or SH3-C domains. Rap1 acti-
vation was assessed as previously described. 
(F) Cells were transfected and stimulated as in 
B, and C3G was puriﬁ   ed using a GST-CrkL 
SH3-N fusion protein and subsequently blot-
ted using the indicated antibodies. (G) Puriﬁ  ed 
human CD4 
+   T cells were transfected with the 
indicated siRNAs, stimulated with anti-CD3, 
and Rap1 activation and phosphorylation of 
CrkL was analyzed by immunoblot. Numbers 
below top blots are arbitrary units based on 
densitometric analysis of the immunoblots. 
Black lines indicate that intervening lanes have 
been spliced out.     JCB • VOLUME 182 • NUMBER 6 • 2008  1238
volved in regulating signaling pathways leading to the activation of 
Rap1. To test this hypothesis, we initially treated human CD4 
+  
T cells with increasing concentrations of the Abl tyrosine kinase 
inhibitor Imatinib (Gleevec, STI-571) and assessed TCR-stimu-
lated Rap1 activation and adhesion. Indeed, concentrations of Ima-
tinib that suffi  ciently blocked phosphorylation of CrkL (5 and 
10   μ  M) also resulted in impaired TCR-stimulated Rap1 activa-
tion and adhesion (Fig. S5, A  –  C). Because of the possibility that 
Imatinib could have off-target effects and/or inhibit the Abl-related 
kinase Arg, we decided to specifi  cally target Abl using RNAi to 
directly examine the role of Abl in TCR-stimulated Rap1 activa-
tion and adhesion. Consistent with the Imatinib experiment, 
siRNA-mediated depletion of Abl from primary CD4 
+   T  cells 
resulted in diminished TCR-stimulated Rap1 activation (  Fig. 7 A  ) 
and Mst1 phosphorylation (  Fig. 7 B  ) but had no effect on up-
stream signaling components such as phosphorylation of PLC   1 
with anti-CD3 resulted in an increase in the amount of both 
WAVE2 and Abl in the membrane fraction of control cells but 
not in WAVE2-suppressed cells (  Fig. 6 C  ). In fact, there appears 
to be more Abl in the cytoplasm of TCR-stimulated WAVE2-
suppressed cells (  Fig. 6 C  ). Interestingly, reprobing of these 
membranes indicates that WAVE2 suppression not only affects 
Abl membrane recruitment but also affects the recruitment of 
CrkL and C3G into the membrane fraction. Collectively, these 
data indicate that the WAVE2 complex is involved in the local-
ization of Abl and the CrkL  –  C3G complex into the plasma 
membrane after TCR ligation. 
  Abl tyrosine kinase regulates 
TCR-stimulated Rap1 activation 
 The  fi  nding that Abl localization is defective in WAVE2-
suppressed cells indicated that Abl kinase activity might be in-
  Figure 6.       The Abl tyrosine kinase interacts with and is localized to the membrane by the WAVE2 complex.   (A) Puriﬁ  ed human T cells were stimulated 
with anti-CD3. WAVE2 was immunoprecipitated and bound proteins were immunoblotted as indicated. (B) Control or WAVE2-suppressed Jurkat T cells 
(green) were allowed to form conjugates with antigen-pulsed Nalm 6 B cells (blue) and then stained for Abl (red). The percentage of T  –  B cell conjugates 
showing Abl accumulation at the IS were quantiﬁ  ed as described in the Materials and methods. Error bars represent SD. Bar, 5   μ  m. (C) Jurkat T cells were 
transfected with either control or WAVE2 suppression vector and stimulated with anti-CD3. Subsequently, cytosolic and membrane fractions were collected 
as described in Materials and methods and immunoblotted with the indicated antibodies. Numbers below blots are arbitrary units based on densitometric 
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C3G was only modestly affected in Abl-suppressed T cells 
(  Fig. 8, A and B  ). Interestingly, suppression of Abl did not 
  affect the recruitment of WAVE2 into the membrane fraction 
after TCR-stimulation (  Fig. 8 B  ). Collectively, these data sug-
gest that the recruitment of CrkL and C3G into the membrane is 
largely dependent on the WAVE2 complex. 
  Although our data indicate that Abl is involved in TCR-
stimulated Rap1 activation, the recruitment of C3G into the 
membrane fraction of Abl-suppressed cells after TCR ligation 
was only moderately affected. It has been previously demon-
strated that Src can phosphorylate Y504 within C3G to regulate 
its GEF activity (  Ichiba et al., 1999  ). We therefore examined 
whether Abl might be involved in the phosphorylation of C3G. 
Using an in vitro kinase assay, we found that although purifi  ed 
Abl kinase can readily phosphorylate a GST fusion protein con-
taining CrkL Y207, it had limited ability to phosphorylate a 
GST fusion protein containing the fragment of C3G containing 
Y504 (  Fig. 8 C  ). This was not because of a problem with the 
fusion protein because the Src kinase Fyn readily phosphorylated 
the GST-C3G protein, as well as a positive control GST fusion 
protein containing Y100 of vinculin (  Fig. 8 C  ). However, when 
(  Fig. 7 C  ) or stability of the WAVE2 complex (Fig. S3 B). 
[ID]FIG7[/ID]  How-
ever, similar to the phenotype of CrkL-, C3G-, and WAVE2-
  suppressed T cells, suppression of Abl in either Jurkat T cells 
(  Fig. 7 D  ) or primary CD4 
+   T cells (  Fig. 7 E  ) resulted in impaired 
TCR-mediated adhesion to fi  bronectin and in the ability to bind 
soluble VCAM-1-Fc in response to both TCR and PMA stimu-
lation (  Fig. 7 F  ). Overall, these data demonstrate that the Abl 
tyrosine kinase is involved in a TCR signaling pathway, leading 
to Rap1 activation and integrin affi  nity maturation. 
  Effect of Abl on CrkL  –  C3G membrane 
recruitment and activation 
  Because our data suggests that Abl regulates TCR-stimulated 
Rap1 activation and WAVE2 is involved in the recruitment 
of Abl into the membrane after TCR ligation, we reasoned 
that Abl might affect the membrane localization or activation 
of the CrkL  –  C3G complex. Consistent with the biochemical 
data shown in   Fig. 6 C  , we fi  nd that CrkL localization to the 
cell  –  bead contact site is affected in WAVE2-suppressed T cells 
( Fig.  8  A ). 
[ID]FIG8[/ID]  In contrast, localization of CrkL to the cell  –  bead 
contact site, as well as the membrane recruitment of CrkL and 
  Figure 7.       Abl regulates TCR-mediated activation of Rap1 and integrin afﬁ  nity maturation.   (A) Puriﬁ  ed human CD4 
+   T cells were transfected with the indi-
cated siRNAs, and Rap1 activation was assessed after anti-CD3 cross-linking. Numbers below top blot are arbitrary units based on densitometric analysis 
of the immunoblots. (B) Same as A, except whole cell extracts were collected and analyzed by immunoblot for pMst1, Mst1, and Abl. (C) Jurkat T cells 
were transfected with suppression vectors against Abl (Abl-1 and Abl-3), stimulated with anti-CD3, and cell extracts were analyzed for pPLC    1 (Y783), 
PLC    1, pCrkL (Y207), CrkL, and Abl. (D and E) Jurkat T cells (D) or primary human CD4 
+  T cells (E) were suppressed for Abl and basal, and anti-CD3 and 
PMA-stimulated adhesion to ﬁ  bronectin was analyzed as described in   Fig. 1  . Error bars represent SD. (F) Jurkat T cells were transfected with the indicated 
GFP-expressing suppression vector cells and analyzed for their ability to bind soluble VCAM-1-Fc as in   Fig. 4 B  .     JCB • VOLUME 182 • NUMBER 6 • 2008  1240
  Discussion 
  Multiple studies have indicated that Rap1 regulates integrin 
clustering and affi  nity maturation in T cells. However, the sig-
naling pathways initiated by the TCR that result in Rap1 activation 
remain relatively obscure. Our data demonstrate that the WAVE2 
complex is an essential component of the TCR-stimulated sig-
naling pathway, leading to activation of both Rap1 and its down-
stream effectors. Furthermore, our data suggest that WAVE2 
regulates Rap1 activation through an Abl kinase-dependent mecha-
nism that results in recruitment and activation of the CrkL  –  C3G 
exchange complex. 
  The data presented here are intriguing when combined 
with our earlier work showing that vinculin and talin are re-
cruited to the IS via the VCA domain of WAVE2 and the Arp2/3 
complex (  Nolz et al., 2007  ). In terms of kinetics, our data sug-
gests that Rap1 activation occurs during the early stages of 
cytoskeletal rearrangement when initial lamellipodial protrusion 
occurs. Because many effectors of Rap1 regulate both integrin 
examining the phosphorylation of C3G in cells, we found that 
suppression of Abl resulted in diminished TCR-stimulated tyro-
sine phosphorylation of C3G (  Fig. 8 D  ). Collectively, these data 
suggest that Abl is involved in the tyrosine phosphorylation of 
C3G after TCR ligation in vivo. 
  WAVE2, Abl, CrkL, and C3G are involved 
in TCR-stimulated interleukin-2 
(IL-2) production 
  To examine the physiological consequence of suppression of 
these mediators of TCR-stimulated integrin activation, we ana-
lyzed the ability of suppressed cells to produce IL-2 upon in-
cubation with superantigen-pulsed Nalm 6 B cells. We reasoned 
that a decrease in the ability to form stable conjugates would 
  affect TCR-stimulated activation of the IL-2 promoter and pro-
duction of this cytokine. Consistent with this notion, we found 
that primary human CD4 
+   T cells suppressed for WAVE2, Abl, 
CrkL, or C3G showed diminished IL-2 secretion compared with 
siRNA control-transfected cells (  Fig. 9  ). 
[ID]FIG9[/ID]  
  Figure 8.       Affect of Abl suppression on 
CrkL  –  C3G membrane localization and activa-
tion.   (A) Jurkat T cells transfected with control, 
WAVE2, or Abl EGFP suppression vectors 
were stimulated with IgG (column 1) or OKT3-
coated beads (columns 2  –  4) and imaged for 
CrkL (aqua) and F-actin (red) recruitment. The 
percentage of EGFP 
+   T cell  –  bead conjugates 
showing localization of CrkL is indicated and 
was performed as described in Materials and 
methods. Representative images are shown. 
Bar, 5   μ  m. (B) Jurkat T cells were transfected 
with the indicated suppression vectors, stimu-
lated by anti-CD3 cross-linking and cytosolic/
membrane fractions, were prepared and 
immunoblotted with the indicated antibodies. 
Numbers below blots are arbitrary units based 
on densitometric analysis of the immunoblots. 
(C) Puriﬁ  ed Abl and Fyn were incubated with 
the indicated GST fusion proteins in kinase buf-
fer, and tyrosine phosphorylation was detected 
by anti-Tyr immunoblotting. Input levels of GST 
were detected by anti-GST immunoblotting. 
Numbers on the left are arbitrary units based 
on densitometric analysis of the immunoblots. 
(D) Jurkat T cells were transfected with the 
indicated suppression vectors, stimulated by 
anti-CD3 cross-linking, and C3G was precipi-
tated as described in   Fig. 5 E  . Proteins were 
detected by immunoblotting with the indicated 
antibodies. Numbers below blots are arbitrary 
units based on densitometric analysis of the 
immunoblots.     1241 WAVE2 REGULATES TCR-MEDIATED RAP1 ACTIVATION   • Nolz et al. 
stimulation, including Cbl (  Donovan et al., 1994  ) and CasL 
(  Kanda et al., 1997  ). In addition, chronic myelogenous leukemia 
cells, which express the BCR-ABL fusion protein, exhibit in-
creases in CrkL, C3G, and CasL phosphorylation (  Salgia et al., 
1996  ). This is accompanied by both increased phosphorylation 
of several focal adhesion proteins and altered cellular adhesion. 
Therefore, it is likely that TCR stimulation causes Abl to acti-
vate the CrkL  –  C3G exchange complex, possibly though CasL, 
leading to Rap1 activation and adhesion. 
  WAVE2 has also been suggested to link to the BCR-ABL 
fusion protein through the adaptor Abi-1 (  Li et al., 2007  ). That 
study indicates that recruitment of Abi and WAVE2 required 
direct interaction with BCR-ABL. This interaction resulted in 
F-actin accumulation, recruitment of several focal adhesion 
proteins including vinculin and talin, and overall increased 
adhesion to fi  bronectin mediated by     1   integrins. In fact, it has 
been shown that Abl phosphorylation of WAVE2 regulates its 
ability to polymerize actin via Arp2/3 (  Leng et al., 2005  ). Con-
sistent with this observation, it was recently shown that Abl is 
involved in the recruitment of WAVE2 and polymerization of 
F-actin at the IS (  Huang et al., 2008  ). Our biochemical and 
microscopy data run contrary to this observation, instead sug-
gesting that WAVE2 recruits Abl into the membrane in response 
to TCR ligation. Additionally, we fi  nd F-actin accumulation at 
the cell  –  bead contact site in Abl-suppressed cells. These in-
consistencies could be caused by the differences in the experimental 
approach. Indeed, when examining T cell  –  B cell interactions, di-
minished adhesion in Abl-depleted cells might affect F-actin 
accumulation and, subsequently, WAVE2 localization. 
 Despite observing a signifi  cant affect on CrkL phosphory-
lation in Abl-suppressed cells and T cells treated with Imatinib, 
we fail to identify a defect in TCR-mediated tyrosine phosphory-
lation of PLC    1 (  Zipfel et al., 2004  ). This suggests that in this 
system, Abl does not function to coordinate proximal TCR sig-
naling events, such as ZAP-70 phosphorylation and forma-
tion of the LAT signalosome, but, rather, Abl appears to work 
in concert with the WAVE2 complex to coordinate cytoskele-
tal dynamics and integrin activation. Yet, we cannot rule out 
the possibility that expression of the Abl-related protein Arg 
could be linking TCR-proximal signaling to PLC-   1,  while 
not being able to couple TCR signaling to CrkL phosphory-
lation, Rap1 activation, or integrin activation. Additionally, the 
level of suppression we attain with RNAi might be insuffi  cient 
to affect TCR proximal signaling but does affect pathways 
leading to integrin activation. However, we do fi  nd that sup-
pression of Abl or treatment with Imatinib does have an impact 
on IL-2 gene transcription. Future studies aimed at identify-
ing mechanisms of WAVE2-independent Abl activity during 
T cell activation will help defi  ne the diverse functions of this 
tyrosine kinase. 
  In conclusion, the data presented here characterizes a pre-
viously unidentifi  ed function of the WAVE2 complex during T 
cell activation. Importantly, WAVE2 not only regulates integrin 
activation through Arp2/3-mediated actin polymerization and 
recruitment of integrins, talin, and vinculin but also mediates 
activation of Rap1 leading to integrin clustering and affi  nity 
maturation. In addition, this study suggests that the WAVE2 
avidity (e.g., Mst1) and affi  nity (e.g., RapL;   Katagiri et al., 2003  , 
  2006  ), WAVE2-dependent activation of Rap1 may help integrins 
localize to areas in the cell where de novo actin polymerization 
is occurring. Finally, as the IS begins to mature, the integrin 
scaffolding proteins vinculin and talin are then recruited to the 
WAVE2  –  Arp2/3 complex to generate the high-affi  nity state of 
the recently recruited integrins by binding both the      chain of 
the integrin and the actin cytoskeleton. 
  Surprisingly, suppression of WAVE2, Abl, CrkL, or C3G 
results in impaired TCR-mediated increases in both integrin 
 affi  nity and avidity. To date, the described effectors of Rap1 
appear to play a more important role in integrin localization 
rather than changing the conformation of the integrin required 
for increasing affi  nity. However, it has been suggested that 
Rap1 may act through RIAM to assist in talin binding to the 
integrin      chain, leading to its high-affi  nity state (  Han et al., 
2006  ). In addition, suppression of Rap1 in T cells results in im-
paired integrin affi  nity in response to chemokine stimulation 
(  Parmo-Cabanas et al., 2007  ). Collectively, these data argue that 
Rap1 is important for both aspects of integrin regulation, even 
though certain Rap1 effectors probably regulate distinct steps 
of the process. 
 Although our data indicate that the activation of the CrkL –
  C3G complex requires WAVE2, the involvement of other adap-
tors is still probable. In fact, many proteins that associate with 
the SH2 domain of CrkL are phosphorylated in response to TCR 
  Figure 9.       Suppression of WAVE2, Abl, CrkL, and C3G affects IL-2 produc-
tion in T cells.   Primary human CD4 
+   T cells were transfected with the indi-
cated siRNA duplexes. After a 72-h incubation, cells were left unstimulated 
or stimulated with Nalm 6 B cells loaded with or without superantigen 
cocktail. 15 h after incubation, the amount or IL-2 in the supernatant was 
determined by ELISA as described in the Materials and methods. Error 
bars represent SD.     JCB • VOLUME 182 • NUMBER 6 • 2008  1242
  Cell stimulation and immunoblot analysis 
  For the stimulation timecourse studies, 10   ×   10 
6   Jurkat T cells or 25   ×   10 
6   
human CD4 
+   T cells were stained on ice with 5   μ  g/ml anti-CD3 (OKT3, 
mAb) and then ligated using goat anti  –  mouse over the indicated time 
course at 37  °  C. After each time point, the cells were immediately washed 
in ice-cold PBS and lysed in NP-40 lysis buffer (20 mM Hepes, pH 7.9, 
100 mM NaCl, 5 mM EDTA, 0.5 mM CaCl, 1% NP-40, 1 mM PMSF, 
10   μ  g/ml leupeptin, 5   μ  g/ml aprotinin, 1 mM Na  3  VO  4  , and 5   μ  M MG-132) 
for 10 min on ice. Lysates were clariﬁ  ed by centrifugation at 18,000   g   for 
5 min at 4  °  C and then transferred to antibody-coated beads. The protein 
complexes were then washed twice with NP-40 lysis buffer, eluted in 60   μ  l 
SDS sample buffer, resolved by SDS-PAGE, and transferred to Immobilon-P 
membranes (Millipore). In cases where whole cell extracts were prepared, 
50  –  100   μ  g of protein was resolved by SDS-PAGE. For immunoblots, anti-
bodies were detected using goat anti  –  mouse IgG or goat anti  –  rabbit IgG 
coupled to HRP (Santa Cruz Biotechnology, Inc.) and SuperSignal Enhanced 
Chemiluminescence (Thermo Fisher Scientiﬁ  c). Bands were quantiﬁ  ed by 
densitometry using Photoshop software (Adobe) and arbitrarily normalized 
to 1. All assays were performed a minimum of three times. 
  Rap1 activation assays 
  Cell stimulation was performed as described in Cell stimulation and immuno-
blot analysis, except 5   ×   10 
6   Jurkat or 10   ×   10 
6   human CD4 
+   T cells were 
used per sample. After washing with cold PBS, cells were lysed in 
1 ml GTPase activation buffer (50 mM Tris, pH 7.5, 500 mM NaCl, 5 mM 
MgCl  2  , 0.5% NP-40, 10% glycerol, 1 mM PMSF, 10   μ  g/ml leupeptin, 
5   μ  g/ml aprotinin, and 1 mM Na  3  VO  4  ) vortexed for 5 s and immediately 
clariﬁ  ed for 10 min by centrifugation at 18,000   g  . 0.5 ml of cell lysates 
were then transferred to glutathione agarose previously bound to GST-Ral-
GDS GBD. Lysates were allowed to rotate for 10 min and washed once 
before elution. Cell extracts were obtained from unused cell lysate after 
clariﬁ  cation. After elution, samples were separated by SDS-PAGE on a 12.5% 
polyacrylamide gel, transferred, and immunoblotting was performed 
for Rap1. 
  Immunoﬂ  uorescence microscopy 
  T cell  –  B cell and T cell  –  bead conjugates were formed essentially as de-
scribed previously (  Cannon et al., 2001  ;   Dombroski et al., 2005  ;   Nolz 
et al., 2007  ). In brief, Nalm 6 B cells were stained with CellTracker Blue 
CMAC (7-amino-4-chloromethylcoumarin; Invitrogen) and pulsed with or 
without 2   μ  g/ml SEE (Toxin Technology, Inc.). B cells were centrifuged 
together with the same number of T cells, incubated at 37  °  C for 15 min, 
plated onto poly-  L  -lysine  –  coated coverslips, and ﬁ  xed with 4% PFA/PBS for 
10 min at room temperature. For T cell  –  bead conjugates, 10 
6   cells/ml 
were incubated with IgG- or anti-CD3  –  coated beads (10 
6  /ml) in 0.5 ml 
of total volume, centrifuged at 450 rpm for 5 min, incubated at 37  °  C for 
10 min, plated onto poly-  L  -lysine  –  coated coverslips, and ﬁ  xed with 4% 
PFA/PBS for 10 min at room temperature. Fixed cells were quenched with 
50 mM NH  4  Cl and permeabilized in 0.2% Triton X-100. Blocking and anti-
body incubations were performed in blocking buffer (PBS, 0.05% saponin, 
and 0.25% ﬁ  sh skin gelatin). Slides were labeled with puriﬁ  ed anti-CrkL, 
anti-      1   integrin antibody (clone P5D2; Millipore), or anti-Abl (clone 8E9; 
BD Biosciences), followed by goat anti  –  mouse TRITC, goat anti  –  rabbit FITC 
(Invitrogen), or goat anti  –  rabbit Cy5 (Invitrogen). In some cases, conju-
gates were stained for polymerized F-actin using rhodamine-conjugated 
phalloidin (Invitrogen). Coverslips were mounted in Mowiol 4  –  88 (HOECHST; 
Celanese) containing 10% 1,4-diazobicyclo [2.2.2] octane. Fixed conju-
gates were examined at room temperature on a microscope (Axiovert 200; 
Carl Zeiss, Inc.) with a digital camera (AxioCam HRC; Carl Zeiss, Inc.) 
using a 40  ×  /0.75 NA objective or a scanning confocal microscope (LSM 
510; Carl Zeiss, Inc.) using a 63  ×  /1.2 NA water-immersion objective. 
Images were captured with either the AxioVision or LSM software packages 
(Carl Zeiss, Inc.). Figure construction of images was performed in Photo-
shop and Canvas (ACD Systems). 100 conjugates were scored per condi-
tion, and cells were scored as positive if the T cell had bound a single bead 
or Nalm 6 B cell and demonstrated accumulation of integrin, F-actin, or pro-
tein at the contact area as previously described (  Nolz et al., 2006  ,   2007  ). 
Data are presented as the percentage of cells polarized of the scored conju-
gates   ±  SE for a minimum of three independent experiments. 
  Adhesion assays 
  Adhesion assays were performed in ﬂ  at-bottom 96-well plates. Fibronectin 
or ICAM-1Fc (R  &  D Systems) was diluted in sterile PBS, and wells were 
coated overnight at 4  °  C. Wells were then washed once with PBS, blocked 
with 2.5% BSA in PBS for 2 h at 37  °  C, and washed once more in PBS. 
complex regulates Abl and CrkL  –  C3G   recruitment into the plasma 
membrane, leading to Rap1 activation and integrin-mediated 
adhesion. It will be of interest to determine whether the ubiqui-
tously expressed WAVE2 or its closely related homologues 
WAVE1 and WAVE3 use a similar pathway to regulate integrin 
activation in other cell types after receptor stimulation. 
  Materials and methods 
  Reagents and antibodies 
  Unless otherwise stated, all chemicals were obtained from Sigma-Aldrich. 
The antisera against WAVE2, Abi-1/2, PIR121, HEM-1, PLC    1, LAT, and 
ZAP-70 have been previously described (  Nolz et al., 2006  ). Antibodies for 
CrkL (clone 5  –  6) and phosphotyrosine (clone 4G10) were purchased from 
Millipore. Additionally, a rabbit polyclonal antibody was generated by 
Cocalico Biologicals, Inc. to a KLH-conjugated CrkL peptide (aa 280  –  303) 
and afﬁ  nity puriﬁ  ed using amino link (Thermo Fisher Scientiﬁ  c). The anti-
bodies for phospho-CrkL (Y207), phospho-PLC    1 (Y783), phospho-Pak1 
Thr423 (Mst1 Thr183), total Mst1, and Erk were obtained from Cell Signal-
ing Technology. The antibody for Abl (clone 8E9) was purchased from BD 
Biosciences, and the antibody for C3G (RapGEF1, Clone 3D10) was ob-
tained from Novus Biologicals. The OKT3 mAb antibody was obtained 
from the Mayo Pharmacy and the anti-CD28 mAb was purchased from BD 
Biosciences. 5-  μ  m latex beads were purchased from Invitrogen and la-
beled with IgG or anti-CD3 antibodies as previously described (  Dombroski 
et al., 2005  ). 
  Cell culture and transfection 
  Jurkat T cells and Nalm 6 B cells were grown in RPMI-1640 supplemented 
with 5% FBS, 5% FCS, and 4 mM   L-  glutamine. Human CD4 
+   and CD8 
+   T 
cells were puriﬁ  ed from cells retained in the leukoreduction systems cham-
bers after plateletpheresis from blood donors at the Mayo Clinic Blood 
Bank using RosetteSep puriﬁ  cation (StemCell Technologies Inc.). After puri-
ﬁ   cation, human CD4 
+   T cells were cultured in serum containing media 
along with 5   μ  g/ml PHA and IL-2 for 24 h. Cell were then washed and cul-
tured in serum containing media with IL-2 for 72 h. Transient transfections 
in Jurkat were performed using 10 
7   cells per sample along with 30  –  40   μ  g 
of plasmid DNA as previously described (  Cao et al., 2002  ). Transfected 
Jurkat cells were used 48  –  72 h after transient transfection. 
  Plasmids and cloning 
  The pFRT and pCMS3 suppression vectors and the pCMS4 suppression/
reexpression vector used for shRNA silencing and reexpression of re-
sistant cDNAs have been described previously (  Gomez et al., 2005  ). 
The following 19-nucleotide sequence was generated to target human 
WAVE2: GAGAAGAGAAAGCACAGGAA. The following sequence was 
used to target human CrkL: GAGGGCATTGACTGGTTAA. C3G was tar-
geted using the following two sequences: a, GGGTTGTGTGAACTG-
AAAT; and b, GCCGGGATCCAGGAGAATG. Abl was targeted using the 
following two sequences: 1, GGGAGGGTGTACCATTACA; and 3, GGAAA-
TCAGTGACATAGTG. Human CrkL was cloned from Jurkat cDNA using stan-
dard methods. Mutants of CrkL (SH2:R39A, SH3-N:W160Y,W161Y; SH3-C:
W275Y,W276Y) were created using the Quick Change Site-Directed 
Mutagenesis kit (Stratagene) and cloned as a FLAG-tagged protein. The 
wild-type and     VCA versions of WAVE2 used in the suppression/
re  expression vectors have been previously described (  Nolz et al., 2007  ). 
Myc-tagged Rap1 and GFP-tagged PKD have been described previously 
(  Medeiros et al., 2005  ). GST-fusion proteins of the SH3 domains of Abi-1 
(438-End), Abi-2 (394-End), IRSp53 (370  –  439), and N-terminal CrkL 
(117  –  179) were generated in bacteria as previously described (  Hamann 
et al., 2007  ). 
  siRNA transfection of puriﬁ  ed human CD4 
+   T cells 
  All siRNAs were purchased from Thermo Fisher Scientiﬁ  c. Transfection of 
siRNA into puriﬁ  ed human CD4 
+   T cells was performed essentially as previ-
ously described (  Gomez et al., 2007  ). In brief, 5  –  6   ×   10 
6   cells were used 
per transfection using 300  –  500 pmol siRNA after T cell isolation and cul-
ture as described in Cell culture and transfection. Cells were then used 72 h 
after transfection. The following sequences were used to target proteins 
in primary human T cells: WAVE2, CACCCGAAAAGCCTTCAGA; CrkL-a, 
GAGGGCATTGACTGGTTAA; CrkL-b, GAGTTCTTTTGGATCATAA; Abl-a, 
GGGAGGGTGTACCATTACA; Abl-b, GGAAATCAGTGACATAGTG; and 
C3G, GGGTTGTGTGAACTGAAAT. 1243 WAVE2 REGULATES TCR-MEDIATED RAP1 ACTIVATION   • Nolz et al. 
shows that Abl coimmunoprecipitates with, but is not an obligate com-
ponent of, the WAVE2 complex. Fig. S4 shows that Abl kinase activity 
is recruited into the membrane fraction after TCR ligation. Fig. S5 shows 
that Imatinib affects TCR-stimulated Rap1 activation and adhesion to ﬁ  -
bronectin. Online supplemental material is available at http://www.jcb
.org/cgi/content/full/jcb.200801121/DC1. 
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